Dec 20- Walgreen Co, the largest U.S. drugstore operator, reported higher quarterly sales on Friday, but an increase in promotions and a slowdown in the introduction of higher-profit generic drugs cut into its gross profit margin. Wasson said the business environment was challenging and said Walgreen would focus on containing costs to protect margins.» Read More
NBC's Tom Costello reports on the outbreak of meningitis tied to a contaminated drug, saying as many as 13,000 people may have received one of the contaminated steroids.
Pharmaceuticals continue to be an attractive sector for earnings and dividend growth, and CNBC's Seema Mody reports on how companies like Pfizer are faring.
Medical experts convening at the American Neurology Association meeting to evaluate phase 3 Alzheimer's data on a drug from Eli Lilly. CNBC's Seema Mody reports.
Lance Armstrong has announced he will no longer fight accusations that he used performance enhancing substances during his cycling career, with CNBC's Erin Sharoni.
One argument made in defense of legalizing pot is an economic one: a boost in revenue from taxes, lower cost in fighting the war on drugs, and even a solution to the nation's energy problem. Kevin Sabet, former White House Advisor on drug policy, and freelance journalist Doug Fine, discuss the war on drugs in the U.S. and the economics involved.
Could President Obama lose Colorado if he does not fix issues facing pot-related businesses? CNBC's Brian Shactman reports.
Wells Fargo tells CNBC they have "opted not to bank" with pot businesses because "while medical marijuana dispensaries are legal in some states, they are still illegal under federal law," reports CNBC's Brian Shactman.
If Amendment 64, which legalizes Marijuana and regulates it like alcohol, passes in Colorado this November, the state could see $64 million more in taxes, reports CNBC's Brian Shactman.
Should Peter Thiel be allowed to stay on Facebook's board since selling his shares. Is the criticism of Nike's $300 shoe fair? And the Candy Lady is making candy that looks like crystal meth, with CNBC's John Carney & Julia Boorstin.
Johnson & Johnson has faced multiple product recalls over the years, with CNBC's Seema Mody. Tony Butler, Barclays, offers insight.
A provision of the Affordable Care Act squeezes premiums that drugmakers collect from the government has yielded savings of $687 million in the first six months of 2012.
Chief William T. Riley, Selma Police Department, discusses the successful raid of a Selma, Alabama gas station where synthetic drugs were confiscated and explains how police warned local stores about the new breed of drugs.
On February 1, 2012, the Selma Police department in Alabama raided a local gas station and confiscated more than $15,000 worth of a new grade of synthetic marijuana called the Blue Bomb. Detective Kendall Thomas describes what was found.
Just in the last month, two weight loss drugs have won the approval of the FDA, reports CNBC's Seema Mody.
CNBC's Eamon Javers reports on an apology made by HSBC's U.S. CEO regarding the money laundering scandal.
Federal prosecutors are uncovering what they say is another blatant rip-off of the Medicaid system, and U.S. Attorney Preet Bharara says 48 people are charged in a nationwide operation centered here in New York, reports CNBC's Scott Cohn.
The "Mad Money" host gets poetic and gives investors a glimpse of how the global economy might be seen through Charles Dickens' eyes.
Wal-Mart is responsible for 11 percent of the total U.S. retail sales, and CNBC's Courtney Reagan reports on the debate between economists over the company's costs and benefits of its impact on the retail landscape.
With the weight loss market heating up, stocks like Arena Pharmaceuticals may be spelling out a big rally for the drug retail space.
Last week, Celgene announced it was pulling its Revlimid application in Europe, and Mad Money host Jim Cramer explains why he thinks investors should buy into the stock now.